HOME
論文＿腫瘍免疫
Matuyoshi H、Senju S、Hirata S、Yoshitake Y、Fukuma D、Motomura Y、Nishimura Y.Cancer immunotherapy by genetically modifed embryonic stem cell-derived dendritic cells.Immunology 2004 （Theproceeding of the 12th International Congress of Immunology、ed.By Skamene、E.）Medimond S.r.l.（Bologna、Italy） 487-491、2004

Matuyoshi H、Senju S、Hirata S、Yoshitake Y、Fukuma D、Motomura Y、Nishimura Y.Cancer immunotherapy by genetically modifed embryonic stem cell-derived dendritic cells.Immunology 2004 （Theproceeding of the 12th International Congress of Immunology、ed.By Skamene、E.）Medimond S.r.l.（Bologna、Italy） 487-491、2004

2021/05/31

Matuyoshi H、Senju S、Hirata S、Yoshitake Y、Uemura Y、Nishimura Y.Enhanced priming of antigen-specific CILs in vivo by embryonic stem cell-derived dendritic cells expressing chemokine along with antigenic protin:application to antotumor vaccination.J.Immunol 172：776-786、2004

Yoshitake Y、Nakatsura T、Monji M、Senju S、Matsuyoshi H、Hirotake T、Hosaka S、Komori H、Fukuma D、Ikuta Y、Katafiri T、Furukawa Y、Itoh H、Shinohara M、Nakamura Y、Nishimura Y.Proliferation potenial-related protein、an ideal esophageal cancer antigen for immunotherapy、idenified using cDNA microarray analysis.Clin.Cancer Res.10：6437-6448、2004

	月	火	水	木	金	土	日
9:00～13:00	●	●	●	●	●	●	×
14:00～18:00	●	●	●	●	●	▲	×

	月	火	水	木	金	土	日
9:00～12:00	●	●	●	●	●	●	×
14:00～16:00	●	●	●	×	●	▲	×